With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.
LSPedia, a software-as-a-service (SaaS) provider that specializes in product traceability solutions for the pharma industry, has partnered with Altro Pharmaceuticals, who provides services to manufacturers and wholesale distributors in the sector, helping them expand their businesses, streamline supply chain operations, and increase efficiency. Now, with this partnership, Altro customers are hoping to be able to easily comply with the Drug Supply Chain Security Act (DSCSA) ahead of the FDA's final deadline on Nov. 27, 2023.
The SaaS provider’s OneScan Suite enables manufacturers and wholesalers to quickly achieve full compliance with all DSCSA requirements, including serialization, sending and receiving EPCIS data, verification, and interoperability. Further, the solution includes access to LSPedia's Investigator for Exceptions Management, which helps alert, resolve, and prevent EPCIS transaction errors.
"Getting DSCSA right is essential to the smooth flow of business in the pharma supply chain, so we take it incredibly seriously, and we absolutely want our customers to succeed with it,” says Sandy Greco, president of Altro Pharmaceuticals.
Elevate Your Commercial Operations with Close-up CRM
September 6th 2024Discover a powerful, cost-effective, and robust CRM platform that maximizes your budget. Seamlessly integrate data from any source, streamline marketing efforts, and optimize HCP promotion, key account management, and digital marketing campaigns. Reduce CRM costs and reallocate funds to enhance data analytics, market research, and human capital, boosting overall commercial operations impact.
AI-Enabled Pharma CRM Driving Intelligent Customer Engagement
September 6th 2024Discover our unparalleled CRM solution that integrates AI/ML for enhanced stability, security, and performance. Leverage our team of 1000+ experts and 25K+ data provider partners. Our cloud-based SaaS model allows rapid global deployment and scalability, while our clean UX focuses on intuitive AI experience and rapid user adoption. Ensure swift 80% physician onboarding with our intuitive AI platform, speeding strategic integration.